Risedronate
ATC M05BA07 · 7 markets · 174 records
GB 69 records · 4 strengths
ES 32 records · 5 strengths
- 35 mgtabletACREL SEMANALACTONEL SEMANAL、RISEDRONATO SEMANAL ABABOR、RISEDRONATO SEMANAL ALTER、RISEDRONATO SEMANAL AUROVITAS PHARMA、RISEDRONATO SEMANAL CINFA、RISEDRONATO SEMANAL COMBIX、RISEDRONATO SEMANAL KERN PHARMA、RISEDRONATO SEMANAL NORMON +5
- 75 mgtabletACRELActonel、ARISOCARE、RISEDRONATO ABABOR、RISEDRONATO AUROVITAS PHARMA、RISEDRONATO CINFAMED、RISEDRONATO COMBIX、RISEDRONATO FARMA QUALIGEN、RISEDRONATO NORMON +1
- 30 mgtabletActonel
- 5 mgtabletActonel
- 35 mgtablet · delayed-releaseACTONEL SEMANAL
US 21 records · 9 strengths
AU 14 records · 6 strengths
- 35 mgtabletAPO-RisedronateRisedronate Sandoz、RISEDRONATE-WGR
- 150 mgtabletActonel Once-a-MonthAPO-Risedronate、Risedronate Way
- 30 mgtabletActonel
- 5 mgtabletActonel
- 35 mgtablet · delayed-releaseActonel EC
Records without a stated strength · 1 Actonel、Actonel EC、APO-Risedronate、Risedronate Sandoz、RISEDRONATE-WGR
CA 5 records · 4 strengths
- 35 mgtabletrisedronateTEVA-RISEDRONATE
- 150 mgtabletTEVA-RISEDRONATE
- 30 mgtabletTEVA-RISEDRONATE
- 5 mgtabletTEVA-RISEDRONATE
TW 2 records · 2 strengths
- 35 mgtabletWalkin 35mg Film-coated歐骨宜膜衣錠35毫克
- 150 mgtabletReosteo 150mg Tablets瑞骨卓150毫克膜衣錠
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in GB and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en GB que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 GB 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 GB 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.